Scott Stromatt
Plus aucun poste en cours
Profil
Scott C.
Stromatt worked as a Director of Medical Affairs at G.D.
Searle & Co., Inc. and as a Vice President of Clinical Research at Synergen, Inc. He was also the EVP of Clinical Development & Regulatory Affairs at CTI BioPharma Corp.
and the Chief Medical Officer & VP of Clinical Research at Northwest Biotherapeutics, Inc. He served as the Senior Vice President at C.E.
Unterberg, Towbin Holdings, Inc. and as the Chief Medical Officer & Senior Vice President at Emergent Product Development Seattle and Emergent BioSolutions, Inc. He was also the Chief Medical Officer & SVP of Clinical Development at Aptevo Therapeutics, Inc. Dr. Stromatt earned a doctorate degree from The University of Chicago and an undergraduate degree and an MBA from The University of Colorado.
Anciens postes connus de Scott Stromatt
| Sociétés | Poste | Fin |
|---|---|---|
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Chief Tech/Sci/R&D Officer | 01/08/2016 |
| CTI BIOPHARMA CORP. | Chief Tech/Sci/R&D Officer | 01/01/2008 |
| NORTHWEST BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 02/10/2003 |
C. E. Unterberg, Towbin, Inc.
 C. E. Unterberg, Towbin, Inc. Investment Banks/BrokersFinance C. E. Unterberg, Towbin is a global investment bank headquartered in New York City with additional offices in California and Israel. The firm provides investment banking, research and investment management services to emerging growth companies and investors in the technology, health care and defense, security and diversified technology sectors. C. E. Unterberg was founded in 1932 by Clarence Unterberg. In 1977, the firm merged with L. F. Rothschild to form L. F. Rothschild, Unterberg, Towbin. In 1990, the firm again became privately owned and independent when Clarence Unterberg's son, Thomas I. Unterberg, re-launched the firm as a full-service investment bank. | Analyst-Equity | 18/02/2002 |
| APTEVO THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Scott Stromatt
| The University of Chicago | Doctorate Degree |
| The University of Colorado | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NORTHWEST BIOTHERAPEUTICS, INC. | Health Technology |
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| APTEVO THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
| Synergen, Inc. | Utilities |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
C.E. Unterberg, Towbin Holdings, Inc.
 C.E. Unterberg, Towbin Holdings, Inc. Investment ManagersFinance Part of Canaccord Genuity Group, Inc., C.E. Unterberg, Towbin Holdings, Inc. provides financial advisory services. The private company is based in New York, NY. | Finance |
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
C. E. Unterberg, Towbin, Inc.
C. E. Unterberg, Towbin, Inc. Investment Banks/BrokersFinance C. E. Unterberg, Towbin is a global investment bank headquartered in New York City with additional offices in California and Israel. The firm provides investment banking, research and investment management services to emerging growth companies and investors in the technology, health care and defense, security and diversified technology sectors. C. E. Unterberg was founded in 1932 by Clarence Unterberg. In 1977, the firm merged with L. F. Rothschild to form L. F. Rothschild, Unterberg, Towbin. In 1990, the firm again became privately owned and independent when Clarence Unterberg's son, Thomas I. Unterberg, re-launched the firm as a full-service investment bank. | Finance |
